Associated Press: “A British company, GW Pharma, is in advanced clinical trials for the world’s first pharmaceutical developed from raw marijuana instead of synthetic equivalents – a mouth spray it hopes to market in the U.S. as a treatment for cancer pain. And it hopes to see FDA approval by the end of 2013. Sativex contains marijuana’s two best known components—delta 9-THC and cannabidiol—and already has been approved in Canada, New Zealand and eight European countries for a different usage, relieving muscle spasms associated with multiple sclerosis.”
Pot-based Prescription Drug Looks for FDA OK
By On the Net|2015-04-06T18:53:10-07:00January 23rd, 2012|Stories & Articles|Comments Off on Pot-based Prescription Drug Looks for FDA OK
About the Author: On the Net
The author of this article is
Richard Keyt, an Arizona business law attorney who is the creator of this Arizona medical marijuana law website. Connect with Richard at 480-664-7478 or on Google+